Atlas Trials

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Clinical trial NCT03455322 · COMPLETED

Trial details

NCT number
NCT03455322
Sponsor
National Hepatology & Tropical Medicine Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Impairment in Hepatorenal Syndrome
Start date
2018-08-15
Primary completion
2020-04-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.